Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for UFPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.102M
March 31, 2026 -1.688M
December 31, 2025 -3.856M
September 30, 2025 -15.27M
June 30, 2025 -5.65M
March 31, 2025 -2.817M
December 31, 2024 -3.884M
September 30, 2024 -197.17M
June 30, 2024 -7.381M
March 31, 2024 -1.732M
December 31, 2023 -2.756M
September 30, 2023 -2.785M
June 30, 2023 -2.77M
March 31, 2023 -2.177M
December 31, 2022 -2.964M
September 30, 2022 33.40M
June 30, 2022 -6.168M
March 31, 2022 -22.98M
December 31, 2021 -97.23M
September 30, 2021 -0.965M
June 30, 2021 -1.812M
March 31, 2021 -1.449M
December 31, 2020 -1.309M
September 30, 2020 -0.828M
June 30, 2020 -1.117M
Date Value
March 31, 2020 -1.007M
December 31, 2019 -1.393M
September 30, 2019 -1.562M
June 30, 2019 -1.431M
March 31, 2019 -1.388M
December 31, 2018 -0.907M
September 30, 2018 -1.521M
June 30, 2018 -1.469M
March 31, 2018 -78.43M
December 31, 2017 -3.501M
September 30, 2017 -2.409M
June 30, 2017 -3.007M
March 31, 2017 -1.458M
December 31, 2016 -1.206M
September 30, 2016 -1.717M
June 30, 2016 -2.758M
March 31, 2016 -1.598M
December 31, 2015 -3.296M
September 30, 2015 -2.542M
June 30, 2015 -1.939M
March 31, 2015 -8.491M
December 31, 2014 -2.468M
September 30, 2014 -3.601M
June 30, 2014 -5.878M
March 31, 2014 -1.377M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Abbott Laboratories -673.00M
AngioDynamics, Inc. -1.27M
Alphatec Holdings, Inc. -22.72M
AtriCure, Inc. -3.766M
Baxter International, Inc. -117.00M